However, no significant difference was observed between the expressions of GFAP in the SCH group and the SCH + ADP group (P > 0.05, Figure 4(e)), indicating that ERK1/2 inhibitor SCH blocked the upregulation of ADP on GFAP. The gene discussed is MAPK3; the disease is spindle cell hemangioma.